Bridgefront Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,561
Closed -$737K 652
2025
Q4
$737K Sell
3,561
-2,677
-43% -$529K 0.19% 186
2025
Q3
$1.16M Buy
+6,238
New +$1.07M 0.34% 65
2025
Q1
Sell
-2,689
Closed -$389K 743
2024
Q4
$389K Buy
+2,689
New +$417K 0.13% 279
2024
Q3
Sell
-4,306
Closed -$629K 626
2024
Q2
$629K Buy
4,306
+1,079
+33% +$160K 0.26% 122
2024
Q1
$510K Buy
+3,227
New +$514K 0.39% 70
2023
Q4
Sell
-1,418
Closed -$221K 466
2023
Q3
$221K Buy
+1,418
New +$234K 0.15% 299
2023
Q2
Sell
-8,791
Closed -$1.36M 575
2023
Q1
$1.36M Buy
8,791
+5,921
+206% +$956K 0.83% 8
2022
Q4
$507K Buy
2,870
+779
+37% +$135K 0.35% 95
2022
Q3
$342K Buy
+2,091
New +$354K 0.35% 105
2022
Q2
Sell
-3,950
Closed -$700K 377
2022
Q1
$700K Buy
+3,950
New +$672K 0.86% 18
2021
Q2
Sell
-7,922
Closed -$1.3M 757
2021
Q1
$1.3M Buy
+7,922
New +$1.28M 0.41% 29

Other funds holding JNJ

Bridgefront Capital's JNJ Position: Q1 2026 in Review

Bridgefront Capital sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 3,561 shares — an estimated $737K sold.

Bridgefront Capital first reported a position in JNJ in Q1 2021 and held it in 11 quarters. The position peaked at $1.36M in Q1 2023. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Bridgefront Capital reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Bridgefront Capital sold 3,561 Johnson & Johnson shares in Q1 2026, an estimated $737K.
  • Bridgefront Capital first reported a position in Johnson & Johnson in Q1 2021 and held it in 11 quarters.
  • Bridgefront Capital's Johnson & Johnson position peaked at $1.36M in Q1 2023.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.